Combination therapy could improve outcomes in the most difficult-to-treat patients with inflammatory bowel disease

For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy is showing results that offer hope for one of medicine's most treatment-resistant populations, according to findings from two studies presented at Digestive Disease Week (DDW